When good specialists from a healthcare team move on, it can disrupt a patient's world, writes columnist Mary Shaniqua. But ...

VAS-101, a curcumin-based gel for SCD, was well tolerated and showed signs of easing sickle cell pain, fatigue, and red blood ...

Children with sickle cell anemia who undergo stem cell transplant tend to have better long-term cognition than those on ...

The Boozer brothers have joined with NMDP to encourage young adults to register as blood stem cell donors and support ...

I wasn’t supposed to be writing my next column yet. In fact, I specifically requested that this piece be published on June 19, World Sickle Cell Day. For me, the day is more than an awareness campaign ...

Agios Pharmaceuticals’ medication mitapivat rapidly increased levels of the oxygen-carrying protein hemoglobin in patients ages 16 and older with sickle cell disease (SCD), while also being linked to ...

Fulcrum Therapeutics said it is discontinuing development of pociredir, its experimental oral treatment for sickle cell disease (SCD), after the U.S. Food and Drug Administration (FDA) raised concerns ...

An experimental, single-dose gene-editing therapy from Tessera Therapeutics successfully corrected the genetic mutation that causes sickle cell disease (SCD) in the majority of blood-forming stem ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Nearly every person with sickle cell disease (SCD) who underwent ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google The quiet, creeping isolation that comes with living with sickle ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Children with sickle cell anemia (SCA), the most common and ...

Beam Therapeutics plans to ask the U.S. Food and Drug Administration (FDA) to approve ristoglogene autogetemcel, or risto-cel, its single-dose, gene-edited cell therapy candidate for people with ...